Joseph  C. Wu, MD, PhD

Joseph C. Wu, MD, PhD


Director, Stanford Cardiovascular Institute, Simon H. Stertzer, MD, Professor and Professor of Radiology

View Professional Summary »

Additional Languages Spoken:
Mandarin , Taiwanese


Dr. Wu is a board-certified cardiologist. He is the director of the Stanford Cardiovascular Institute and the Simon H. Stertzer, MD, Professor of Medicine and Radiology at Stanford University School of Medicine. His clinical interests include adult congenital heart disease and cardiovascular imaging. He strives to help each patient achieve the best possible heart health and quality of life.

The American Heart Association appointed Dr. Wu as its president for fiscal year 2023-2024.

To advance heart care, Dr. Wu conducts extensive research, focusing on clinical genomics, stem cells, and drug development. The goals of his research are to enhance our understanding of cardiovascular diseases, accelerate the discovery of new drug treatments, and ensure that every cardiovascular patient will benefit from the best of personalized precision medicine being developed at Stanford Medicine.

Dr. Wu has published more than 650 manuscripts with H-index of 133. He is recognized as top 0.1% of highly cited researchers in Web of Science for past 6 years (2018, 2019, 2020, 2021, 2022, 2023) in the fields of cardiovascular medicine, stem cells, genomics, and precision medicine. His work has appeared in peer-reviewed journals including Nature, Cell, Science, Nature Medicine, Nature Methods, Science Translational Medicine, Cell Stem Cell, PNAS, Circulation, Journal of the American College of Cardiology, European Heart Journal, and many more. Dr. Wu also educates the heart specialists of the future. More than 50 of his trainees are now principal investigators of clinical or research studies in major academic centers both in the US and internationally.

Dr. Wu has earned numerous honors, including the Distinguished Scientist Award from the American Heart Association, NIH Director’s New Innovator Award, and NIH Director's Transformative Research Award. He also received the Presidential Early Career Award for Scientists and Engineers (PECASE) from the White House Office of Technology.

Dr. Wu is an elected member of the National Academy of Medicine (NAM), National Academy of Inventors (NAI), American Association for the Advancement of Science (AAAS), American Society for Clinical Investigation (ASCI), Association of American Physicians (AAP), Academia Sinica (Taiwan), Association of University Cardiologists (AUC), and American Institute for Medical and Biological Engineering (AIMBE).

Dr. Wu is an honorary lifetime member of the Society of Toxicology (SOT). He also serves on the FDA Cellular, Tissue, and Gene Therapies Advisory Committee. He is co-founder of Greenstone Biosciences, a startup that uses clinical genomics, patient-specific iPSCs, and AI/ML to accelerate drug discovery.

For more information, please visit his lab website:

Professional Summary

Education & Certifications
  • Medical Education: Yale School Of Medicine (1997) CT
  • Fellowship, UCLA Medical Center, Cardiovascular Medicine (2004)
  • PhD, UCLA, Molecular & Medical Pharmacology (2004)
  • MD, Yale University School of Medicine, Medicine (1997)
  • BS, UCLA, Biology (1993)

Honors & Awards
  • Academician, Academia Sinica (2022)
  • Awardee, Gill Heart & Vascular Institute Cardiovascular Research Award (2023)
  • Board of Directors, Keystone Symposia (2022)
  • Council Member, American Society Clinical Investigation (2014-2017)
  • Distinguished Investigator Award, Academy of Radiology Research (2014)
  • Distinguished Scientist Award, American Heart Association (2018)
  • Established Investigator Award, American Heart Association (2013)
  • Highly Cited Researcher (Top 1% in Web of Science), Clarivate Analytics (2018-2021)
  • Honorary Lifetime Member, Society of Toxicology (2021)
  • Joseph A. Vita Award, American Heart Association (2015)
  • Member, American Association for the Advancement of Science (2019)
  • Member, American Institute for Medical and Biological Engineering (2018)
  • Member, American Society Clinical Investigation (ASCI) (2012)
  • Member, Association of American Physicians (AAP) (2015)
  • Member, Association of University Cardiologists (AUC) (2013)
  • Member, National Academy of Inventors (2022)
  • Member, National Academy of Medicine (2019)
  • Merit Award, American Heart Association (2017)
  • NIH Director's New Innovator Award, National Institutes of Health (2008-2013)
  • NIH Roadmap Transformative Award, National Institutes of Health (2009-2014)
  • President, American Heart Association (2023)
  • President-Elect, American Heart Association (2022)
  • Presidential Early Career Award for Scientists and Engineers (PECASE), White House Office of Technology (2010)

  • Editorial Board, StemJournal (2018 - Present)
  • Senior Advising Editor, Cardiovascular Research (2018 - Present)
  • Advisory Board, Nature Reviews Cardiology (2017 - Present)
  • Chair, AHA Research Committee (2017 - Present)
  • Member, AHA National Board of Directors (2017 - Present)
  • Member, Cellular, Tissue, and Gene Therapies Advisory Committee (FDA) (2017 - Present)
  • Editorial Board, International Journal of Cardiology (2016 - Present)
  • Associate Editor, Circulation Research (2015 - Present)
  • Editorial Board, Scientific Report (2015 - Present)
  • Editorial Board, Current Cardiovascular Imaging Reports (2015 - Present)
  • Editorial Board, Current Protocols in Stem Cell Biology (2015 - 2017)
  • Editorial Board, Cytotherapy (2014 - Present)
  • Scientific Advisory Board Member, Keystone Symposia (2014 - Present)
  • Editorial Board, Physiological Genomics (2013 - 2016)
  • Editorial Board, Journal Clinical Investigation (2012 - Present)
  • Editorial Board, Molecular Therapy (2011 - Present)
  • Editorial Board, Stem Cell Research (2011 - Present)
  • Editorial Board, Journal Geriatric Cardiology (2011 - 2015)
  • Editorial Board, Human Gene Therapy (2009 - Present)
  • Editorial Board, Journal Nuclear Cardiology (2009 - 2018)
  • Editorial Board, Circulation: Cardiovascular Imaging (2008 - Present)
  • Editorial Board, JACC: Cardiovascular Imaging (2008 - 2018)

Administrative Appointments
  • Director, Stanford Cardiovascular Institute (2013 - Present)


Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Practice Locations

General Cardiology at Boswell Building Stanford, CA
Stanford, CA

300 Pasteur Drive , 2nd Floor, Room A260

Stanford , CA 94305

(650) 725-5909

Make An Appointment More Clinic Information » Getting Here »

Referring Physicians